Pharmacoeconomics and Health Economics

Pharmacoeconomics and Health Economics - Full-Service Provided by Dr. Oestreich + Partner GmbH

In the health services and pharmacoeconomic research areas of medicinal product and medical device research and development, we provide a full spectrum of services from the planning and realisation, through to the statistical analysis and reporting of health economic studies. In the framework of our CRO (Clinical Research Organisation) operations we have long-standing experience in the assessment of product life cycles. As a full-service CRO, we provide pre- and post-marketing in addition to prevention research, which complements our range of services in the area of pharmacoeconomics and health services research. Central access to all results and analyses is enabled through interactive software solutions that highlight all health economic relevant aspects.

Pharmacoeconomics and Health Economics for Pharmaceutical Products, Medicinal Products and Medical Devices

The company, Dr. Oestreich + Partner GmbH, provides professional support to its customers with respect to the optimisation of the cost-benefit ratio from the health economics and pharmacoeconomics viewpoints. Client companies include manufacturers of pharmaceuticals, biotechnology products, medical devices and diagnostic equipment, in addition to clinics, insurance companies and health care institutions.  We carry out pharmacoeconomic / health economic projects to include concurrent pricing and the assessment of cost reimbursement for medicinal products and medical devices. We also provide telemedicine systems for patient self-monitoring. Furthermore, we conduct training, presentations and seminars for doctors, patients, companies and other target groups - from expert research in the area(s) of interest to the development of analysis, assessment and summary reports. In addition, Dr. Oestreich + Partner GmbH manages health economics activities on behalf of its customers in the medicinal products and medical devices industries, to include the filing of applications and making presentations to authorities, in addition to pricing and the development of dossiers on the cost effectiveness of products.

In all of the services we provide in the area of health economics and cost effectiveness studies, our experienced personnel ensures the quality of results through a close working relationship and a customer-oriented partnership, and by adhering to international standards. Our team, which is continuously expanding, comprises experts from various disciplines who draw on many years of experience in this area.

You can find out more about our services in the section “Cost Effectiveness Studies, Medicinal Products, Pharmacoeconomics and Medical Devices” - Click here!

EMA Pharmacovigilance
Health care studies
Observational studies
EMA Pharmacovigilance
Medical Biometrics
Approval of Medical Devices
Clinical Investigators
Clinical Trials
GCP Legislation
GCP - Good Clinical Practice
GCP Guidelines
GCP Compliance
Clinical Research Organisation
Contract Research Organisation
Pharmacoeconomics, Health
Pharmacoeconomic studies
Patient Monitoring
Monitoring Clinical Trials
Clinical Monitor
Marketing Authorisation
Medicinal Product Approval
Drug safety
Data management plan
Clinical development
Monitoring investigators
Non-interventional studies (NIS)
Patient recruitment
Phase IV studies
Investigator audit
Investigator qualification
Investigator selection

EMA Pharmacovigilance · Health care studies · Observational studies · EMA Pharmacovigilance · Medical Biometrics · Approval of Medical Devices · Pharmacovigilance · Clinical Investigators · Clinical Trials · GCP Legislation · GCP - Good Clinical Practice · ICH GCP E6 · GCP Guidelines · GCP Compliance · BfArM GCP · Clinical Research Organisation · Contract Research Organisation · PSUR · PSURs · Pharmacoeconomics, Health · Pharmacoeconomic studies · Pharmacoeconomics · Patient Monitoring · Monitoring Clinical Trials · Clinical Monitor · Marketing Authorisation · Medicinal Product Approval · Drug safety · Data management plan · Clinical development · Monitoring investigators · Non-interventional studies (NIS) · Patient recruitment · Phase IV studies · Investigator audit · Investigator qualification · Investigator selection